Researchers at Orygen and La Trobe University in Melbourne, Australia have completed a rapid review of contemporary epidemic and pandemic research to assess the potential impact of COVID-19 on people with psychosis.
The review, published online ahead of print in Schizophrenia Research, found an increase in the prevalence of psychosis as a result of COVID-19 would likely be associated with viral exposure, pre-existing vulnerability and psychosocial stress. The review also suggested that people with psychosis may present a major challenge and potential infection control risk to clinical teams working with them.
Read more at: https://neurosciencenews.com/coronavirus-psychosis-16378/